Ohio Innovation Fund was among the shareholders who returned for Enable Injections’ latest round.

Enable Injections, a US-based medical device developer, has raised $215m in a series C round featuring Ohio Innovation Fund, the venture capital vehicle co-founded by Ohio State University, Ohio University and Kent State University.

Magnetar Capital led the round, which also attracted Cincinnati Children’s Hospital Medical Center, CincyTech, Cintrifuse, GCM Grosvenor, Squarepoint Capital, Woody Creek Capital Partners and unnamed others.

Enable Injections is working on a drug delivery technology that…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Thierry Heles

Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).
email
Linked in